Artery reopening is required for the neurorestorative effects of angiotensin modulation after experimental stroke

Ahmed Alhusban, Anna Kozak, Wael Eldashan, Adviye Ergul, Susan C. Fagan

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background: Blood flow restoration with fibrinolysis and thrombectomy is recommended to limit injury in stroke patients with proximal artery occlusion. Angiotensin receptor blockers have been shown to be neuroprotective in models of permanent and temporary occlusion, but the benefits on expression of trophic factors have been seen only when the artery is reopened. It is possible that early artery opening with endovascular intervention may increase the likelihood of identifying an effective combination therapy for patients. Methods: Normotensive male Wistar rats were subjected to mechanical middle cerebral artery occlusion (either temporary or permanent), followed by randomization to receive candesartan (0.3 mg/kg IV) or saline. Functional outcome, infarct size, and biochemical changes were assessed 24 h after ischemia induction. Results: Lack of reperfusion blunted candesartan induced neuroprotection (p < 0.05) and reduced the improvement of functional outcome (p < 0.05). With reperfusion, candesartan increased mature BDNF expression in the contralateral hemisphere (p < 0.05) and activated prosurvival (Akt-GSK3-β) signaling (p < 0.05). Without reperfusion, candesartan significantly reduced VEGF expression and MMP activation and increased NOGO A expression, creating an environment hostile to recovery. Conclusion: Candesartan induced pro-recovery effects are dependent on the presence of reperfusion.

Original languageEnglish (US)
Article number4
JournalExperimental and Translational Stroke Medicine
Volume8
Issue number1
DOIs
StatePublished - Apr 27 2016

Fingerprint

Angiotensins
Arteries
Stroke
Reperfusion
Thrombectomy
Angiotensin Receptor Antagonists
Middle Cerebral Artery Infarction
Brain-Derived Neurotrophic Factor
Fibrinolysis
Random Allocation
Matrix Metalloproteinases
Vascular Endothelial Growth Factor A
Wistar Rats
Ischemia
candesartan
Wounds and Injuries

Keywords

  • AT1 blockers
  • BDNF
  • Ischemic stroke
  • Neuroprotection
  • Reperfusion

ASJC Scopus subject areas

  • Neuroscience (miscellaneous)
  • Cognitive Neuroscience

Cite this

Artery reopening is required for the neurorestorative effects of angiotensin modulation after experimental stroke. / Alhusban, Ahmed; Kozak, Anna; Eldashan, Wael; Ergul, Adviye; Fagan, Susan C.

In: Experimental and Translational Stroke Medicine, Vol. 8, No. 1, 4, 27.04.2016.

Research output: Contribution to journalArticle

Alhusban, Ahmed ; Kozak, Anna ; Eldashan, Wael ; Ergul, Adviye ; Fagan, Susan C. / Artery reopening is required for the neurorestorative effects of angiotensin modulation after experimental stroke. In: Experimental and Translational Stroke Medicine. 2016 ; Vol. 8, No. 1.
@article{f89e94628a5a45778126937d807c602e,
title = "Artery reopening is required for the neurorestorative effects of angiotensin modulation after experimental stroke",
abstract = "Background: Blood flow restoration with fibrinolysis and thrombectomy is recommended to limit injury in stroke patients with proximal artery occlusion. Angiotensin receptor blockers have been shown to be neuroprotective in models of permanent and temporary occlusion, but the benefits on expression of trophic factors have been seen only when the artery is reopened. It is possible that early artery opening with endovascular intervention may increase the likelihood of identifying an effective combination therapy for patients. Methods: Normotensive male Wistar rats were subjected to mechanical middle cerebral artery occlusion (either temporary or permanent), followed by randomization to receive candesartan (0.3 mg/kg IV) or saline. Functional outcome, infarct size, and biochemical changes were assessed 24 h after ischemia induction. Results: Lack of reperfusion blunted candesartan induced neuroprotection (p < 0.05) and reduced the improvement of functional outcome (p < 0.05). With reperfusion, candesartan increased mature BDNF expression in the contralateral hemisphere (p < 0.05) and activated prosurvival (Akt-GSK3-β) signaling (p < 0.05). Without reperfusion, candesartan significantly reduced VEGF expression and MMP activation and increased NOGO A expression, creating an environment hostile to recovery. Conclusion: Candesartan induced pro-recovery effects are dependent on the presence of reperfusion.",
keywords = "AT1 blockers, BDNF, Ischemic stroke, Neuroprotection, Reperfusion",
author = "Ahmed Alhusban and Anna Kozak and Wael Eldashan and Adviye Ergul and Fagan, {Susan C.}",
year = "2016",
month = "4",
day = "27",
doi = "10.1186/s13231-016-0018-x",
language = "English (US)",
volume = "8",
journal = "Experimental and Translational Stroke Medicine",
issn = "2040-7378",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Artery reopening is required for the neurorestorative effects of angiotensin modulation after experimental stroke

AU - Alhusban, Ahmed

AU - Kozak, Anna

AU - Eldashan, Wael

AU - Ergul, Adviye

AU - Fagan, Susan C.

PY - 2016/4/27

Y1 - 2016/4/27

N2 - Background: Blood flow restoration with fibrinolysis and thrombectomy is recommended to limit injury in stroke patients with proximal artery occlusion. Angiotensin receptor blockers have been shown to be neuroprotective in models of permanent and temporary occlusion, but the benefits on expression of trophic factors have been seen only when the artery is reopened. It is possible that early artery opening with endovascular intervention may increase the likelihood of identifying an effective combination therapy for patients. Methods: Normotensive male Wistar rats were subjected to mechanical middle cerebral artery occlusion (either temporary or permanent), followed by randomization to receive candesartan (0.3 mg/kg IV) or saline. Functional outcome, infarct size, and biochemical changes were assessed 24 h after ischemia induction. Results: Lack of reperfusion blunted candesartan induced neuroprotection (p < 0.05) and reduced the improvement of functional outcome (p < 0.05). With reperfusion, candesartan increased mature BDNF expression in the contralateral hemisphere (p < 0.05) and activated prosurvival (Akt-GSK3-β) signaling (p < 0.05). Without reperfusion, candesartan significantly reduced VEGF expression and MMP activation and increased NOGO A expression, creating an environment hostile to recovery. Conclusion: Candesartan induced pro-recovery effects are dependent on the presence of reperfusion.

AB - Background: Blood flow restoration with fibrinolysis and thrombectomy is recommended to limit injury in stroke patients with proximal artery occlusion. Angiotensin receptor blockers have been shown to be neuroprotective in models of permanent and temporary occlusion, but the benefits on expression of trophic factors have been seen only when the artery is reopened. It is possible that early artery opening with endovascular intervention may increase the likelihood of identifying an effective combination therapy for patients. Methods: Normotensive male Wistar rats were subjected to mechanical middle cerebral artery occlusion (either temporary or permanent), followed by randomization to receive candesartan (0.3 mg/kg IV) or saline. Functional outcome, infarct size, and biochemical changes were assessed 24 h after ischemia induction. Results: Lack of reperfusion blunted candesartan induced neuroprotection (p < 0.05) and reduced the improvement of functional outcome (p < 0.05). With reperfusion, candesartan increased mature BDNF expression in the contralateral hemisphere (p < 0.05) and activated prosurvival (Akt-GSK3-β) signaling (p < 0.05). Without reperfusion, candesartan significantly reduced VEGF expression and MMP activation and increased NOGO A expression, creating an environment hostile to recovery. Conclusion: Candesartan induced pro-recovery effects are dependent on the presence of reperfusion.

KW - AT1 blockers

KW - BDNF

KW - Ischemic stroke

KW - Neuroprotection

KW - Reperfusion

UR - http://www.scopus.com/inward/record.url?scp=84964452175&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84964452175&partnerID=8YFLogxK

U2 - 10.1186/s13231-016-0018-x

DO - 10.1186/s13231-016-0018-x

M3 - Article

VL - 8

JO - Experimental and Translational Stroke Medicine

JF - Experimental and Translational Stroke Medicine

SN - 2040-7378

IS - 1

M1 - 4

ER -